Lake Wells development preparation
Accommodation facilities were completed and borefield drilling mobilisation began. NAIF and conditional EFA financing steps did not themselves constitute cash drawdowns.
This is not a smooth five-year growth story. APC’s Lake Wells potash investment was followed by a large impairment and voluntary administration, before the company returned to a smaller exploration portfolio. The FY2024 profit mainly reflects the restructuring outcome, not a producing mine’s recovery.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Below the prior year-end balance.
After FY2024 restructuring profit.
Positive but a much smaller base.
Non-recurring earnings charge.
Early spending targeted the Lake Wells Sulphate of Potash development. Public funding decisions and conditional facilities were financing steps, not evidence that the full amounts had been drawn or the project had entered commercial production.
After the unsuccessful funding process, the potash tenure was surrendered and camp assets sold. The subsequent focus shifted toward Nexus and Lake Wells gold exploration; the gold and potash projects must not be treated as the same continuing operating asset.
Accommodation facilities were completed and borefield drilling mobilisation began. NAIF and conditional EFA financing steps did not themselves constitute cash drawdowns.
The project was described as pre-construction with design and approvals advanced, but sufficient equity funding had not been achieved.
Exploration carrying value was impaired to the recoverable camp-sale amount. The strategic funding failure and surrender decision were announced in August 2023 after year-end.
Voluntary administration began in December 2023; control returned to directors in February 2024 after the DOCA process. Tenure surrender, rehabilitation and asset sales closed the potash phase.
GMG was acquired in July 2024, adding contiguous Nexus holdings. Resource-linked contingent milestones were not provisioned because they had not been met and were not considered probable.
FY2025 operating cash use was lower than in FY2024, but funding did not fully cover operating and investing outflows. The going-concern disclosure still relied on a near-term equity raising.
A$ million
AI-generated presentation · values from Financial history across a major restructuring; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Financial history across a major restructuring; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Profit / (loss) after tax | (3.734) | (5.579) | (41.606) | 0.477 | (2.439) |
| Operating cash flow | (3.031) | (3.890) | (3.106) | (3.039) | (2.188) |
| Investing cash flow | (8.462) | (17.432) | (2.736) | 1.055 | (0.043) |
| Financing cash flow | 15.913 | 14.389 | 6.254 | 1.887 | 1.613 |
| Closing cash | 7.797 | 0.879 | 1.292 | 1.198 | 0.580 |
Years ended 30 June; A$ million. Historical issuer name Australian Potash is part of the same selected company history.
FY2024 investing cash is positive despite the extracted row caption saying outflows; asset-sale receipts establish the inflow.
FY2023 impairment and FY2024 administration gain make simple profit growth comparisons misleading.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The administration gain exceeded the reported FY2024 profit. It should not be annualised as a recurring return, just as the FY2023 impairment should not be equated with that year’s cash spending.
A$ million
AI-generated presentation · values from Two non-recurring accounting events; no missing values plotted as zero.
A$ million
| Metric | FY2023 | FY2024 |
|---|---|---|
| Impairment expense | (37.761) | 0.000 |
| Gain on voluntary administration | 0.000 | 3.690 |
These are income-statement items, not same-period cash outflows/inflows of identical amounts.
The FY2024 administration gain should not be interpreted as recurring operating profit.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The decline in investing exploration cash reflects the end of the earlier development programme and a changed expense mix. Continuing operating exploration payments remain visible rather than being hidden by a nil investing line.
A$ million
AI-generated presentation · values from Exploration cash moved from development investment to operating expense; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Exploration payments within operating | (0.370) | (0.321) | (0.261) | (1.287) | (1.093) |
| Evaluation/exploration payments within investing | (8.342) | (17.260) | (2.823) | 0.000 | (0.033) |
These cash lines are already included in the totals above. They are not an extra deduction.
Nil investing exploration in FY2024 does not mean no exploration activity: operating exploration payments continued.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Exploration and evaluation | 20.823 | 35.763 | 0.950 | 0.000 |
The FY2023 remaining balance represented the recoverable camp-sale value after impairment. Sale completed during FY2024.
FY2025 detailed exploration carrying value is not supplied in this packet; it is not assumed zero from the prior-year nil.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Impairment produced a FY2023 equity deficiency. The subsequent recapitalisation and administration process restored positive equity, but FY2025 losses reduced the remaining buffer. Positive working capital does not remove the stated funding uncertainty.
A$ million
AI-generated presentation · values from The balance sheet after impairment and recapitalisation; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 29.699 | 37.650 | 2.962 | 1.560 | 0.783 |
| Total liabilities | 5.738 | 4.620 | 5.523 | 0.814 | 0.395 |
| Equity / (deficiency) | 23.961 | 33.031 | (2.561) | 0.746 | 0.388 |
| Working capital / (deficit) | 2.883 | (2.527) | (3.790) | 0.640 | 0.303 |
FY2025 total assets are calculated as total equity plus total liabilities from extracted consolidated figures; other total-asset cells are reported.
Working capital is current assets less current liabilities, not an estimate of future funding runway.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Cash received from convertible debt in FY2025 is shown as a financing inflow, without assuming that the same amount remained outstanding at year-end. The frozen packet does not fully explain the conversion/carrying-value reconciliation, so no unsupported debt roll-forward is added.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Share and option proceeds | 17.064 | 15.474 | 6.443 | 3.001 | 1.433 |
| Cash share-issue costs | (1.056) | (0.902) | (0.189) | (0.229) | (0.320) |
FY2024 additionally includes A$0.884m paid to the administrator within financing.
FY2025 additionally includes A$0.500m of convertible-debt receipts. Neither is included in the share proceeds row.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.